IP Library Granted Patent US 10,634,667
Granted Patent B2
US 10,634,667 · App. 14/848,032 · Granted Apr 28, 2020

Modular point-of-care devices, systems, and uses thereof

Inventors: Tammy Burd (Palo Alto, CA); Ian Gibbons (Newark, CA); Elizabeth A. Holmes (Palo Alto, CA); Gary Frenzel (Palo Alto, MD); Anthony Joseph Nugent (Palo Alto, CA)
Assignee: Theranos IP Company, LLC
G01N33/5304A61B5/15A61B5/151A61B5/150755B01J19/0046B01L3/0262B01L3/5025B01L3/527B01L7/52B01L9/543G01N1/38G01N33/5302G01N33/54326G01N33/54366G01N33/54386G01N33/56966G01N33/57484G01N33/6803G01N33/94G01N35/00732G01N35/00871G01N35/028G01N35/10G01N35/1065G01N35/1074G16H10/40A61B10/007A61B10/0038A61B10/0045A61B10/0051A61B10/0058A61B10/02A61B2010/0074A61B2010/0077B01J2219/005B01J2219/00283B01J2219/00292B01J2219/00315B01J2219/00369B01J2219/00371B01J2219/00385B01J2219/00466B01J2219/00495B01J2219/00693B01J2219/00702B01L3/021B01L7/5255B01L2200/04B01L2200/0689B01L2200/141B01L2200/148B01L2300/0654B01L2300/0829B01L2300/1805B01L2400/043G01N2035/0097G01N2035/00237G01N2035/00851G01N2035/00881G01N2035/1032G01N2035/1034G01N2035/1048G01N2333/475G01N2333/4737G01N2333/71G01N2333/912G01N2333/9129G01N2333/91205G01N2800/26G01N2800/60Y10T29/49826Y10T436/25375
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,634,667
App. No.
14/848,032
Granted
Apr 28, 2020
Kind
B2
Abstract

The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.

Claims (27)

1. A system for detection of an analyte in a biological sample, comprising:

i) a fluidic device comprising a sample collection unit configured to receive the biological sample, a diluent unit configured to contain a diluent and a reagent unit configured to contain a cartridge reagent for running an assay;

ii) an addressable assay unit comprising an interior reaction site having thereon an immobilized binding reagent that is configured to yield a detectable intensity of a signal indicative of the presence of the analyte;

iii) a fluid transfer device configured to transport the diluent to the sample collection unit to form a diluted sample, the diluted sample to the addressable assay unit, and the cartridge reagent to the addressable assay unit;

iv) a device stage configured to move the fluidic device into fluidic communication with the addressable assay unit; and

v) a detection assembly comprising a detector configured to detect the detectable intensity of a signal indicative of the presence of the analyte.

2. The system of claim 1 , wherein the analyte is selected from the group of analyte types consisting of protein analytes, nucleic acid analytes, organic analytes, and inorganic analytes.

3. The system of claim 1 , further comprising a reader assembly configured to engage said fluidic device.

4. The system of claim 1 , wherein at least one of the sample collection unit or the reagent unit is configured to be moved into fluid communication with the addressable assay unit.

5. The system of claim 1 , wherein said detection assembly comprises an optical detector.

6. The system of claim 5 , wherein said optical detector comprises a photodiode, an avalanche photodiode, a photomultiplier (PMT), a photon counting detector, a charge-coupled device, or a pin diode.

7. The system of claim 1 , wherein said detection assembly comprises a plurality of detectors.

8. The system of claim 1 , wherein said detection assembly is configured to detect a signal from a nucleic acid assay, a signal from an immunoassay, or both.

9. The system of claim 1 , wherein said system comprises a system selected from one or more of: a point of care system for detecting analytes in a biological sample; a portable system for detecting analytes in a biological sample; a desk-top system for detecting analytes in a biological sample; and a bench-top system for detecting analytes in a biological sample.

10. The system of claim 1 , wherein said biological sample is selected from the group consisting of blood, serum, plasma, saliva, urine, tears, gastric fluid, digestive fluid, bone marrow, cerebrospinal fluid, stool, semen, vaginal fluid, and liquid extracted from tissue.

11. The system of claim 1 , wherein said biological sample comprises a volume about 1 μL to 100 μL.

12. The system of claim 1 , further comprising a pretreatment unit configured to separate, process, or retrieve a portion of said biological sample, or combinations thereof.

13. The system of claim 1 , wherein the fluid transfer device comprises a pipette head comprising a nozzle.

14. The system of claim 13 , wherein said nozzle is configured to engage a pipette tip.

15. The system of claim 1 , wherein the fluid transfer device is configured to operate according to a protocol.

16. The system of claim 15 , wherein said protocol is configured to be adjustable without requiring modification of the system.

17. The system of claim 1 , wherein the fluid transfer device is configured for automated operation.

18. The system of claim 1 , further comprising a communication assembly, wherein said communication assembly is configured to transmit information.

19. The system of claim 1 , further comprising a communication assembly, wherein said communication assembly is configured to receive information.

20. The system of claim 19 , wherein operation of said system comprises operation according to a protocol, wherein said protocol is configured to incorporate information received by said communication assembly.

21. The system of claim 20 , wherein said protocol is configured to be adjustable without requiring modification of the system.

22. The system of claim 1 , comprising a plurality of addressable assay units and a plurality of diluent units configured to perform at least two assays in parallel.

Assignments (5)
CHANGE OF NAME Recorded Apr 7, 2020
From: THERANOS IP COMPANY LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052329/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 045075/0310 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: THERANOS INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 044838/0909 →
SECURITY INTEREST Recorded Dec 12, 2017
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 044839/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2016
From: BURD, TAMMY; GIBBONS, IAN; HOLMES, ELIZABETH A.; FRENZEL, GARY; NUGENT, ANTHONY JOSEPH
To: THERANOS, INC.
Reel/Frame 038791/0049 →
Continuity (7)
Continuation 14670200 · Mar 26, 2015
Continuation 13893258 · May 13, 2013
Continuation 13889674 · May 8, 2013
Continuation 13326023 · Dec 14, 2011
Continuation 12244723 · Oct 2, 2008
Provisional Application 60997460 · Oct 2, 2007
Related Publication 20150377914A1 · Dec 31, 2015